Medical News

RSS

APN and Cardinal Health sign agreement to help improve practice operations

Aesyntix Physician Network (APN), a leading national group purchasing organization (GPO) for dermatologists and plastic surgeons, today announced it has signed an agreement with Cardinal Health to provide APN members with products and services designed specifically for dermatologists and plastic surgeons.

15 Oct 2009

Postive vote from FDA Advisory Committee for Fampridine-SR 10

Acorda Therapeutics, Inc. today announced the U.S. Food and Drug Administration (FDA) Peripheral and Central Nervous System Drugs (PCNSD) Advisory Committee voted 12 to 1 that clinical data on Fampridine-SR 10 mg twice daily demonstrated substantial evidence of effectiveness as a treatment to improve walking in people with multiple sclerosis (MS) and voted 10 to 2 (1 abstention) that it is clinically meaningful and can be safe for use.

15 Oct 2009

After key vote, Senate still has long way to go on health care reform

The Associated Press breaks down the different health care reform packages in Congress and takes a look at where the bills — five in all — stand after the Senate Finance Committee voted Tuesday to send their bill out of committee.

15 Oct 2009

Nano Gen Teknolojileri to distribute Fluidigm's BioMark and EP1 genetic analysis systems in Turkey

Fluidigm Corporation, the inventor of integrated fluidic circuits (IFCs), has appointed Nano Gen Teknolojileri Ltd. as its exclusive distributor for the BioMark™ and EP1™ Systems for genetic analysis in Turkey. The BioMark System provides significant advantages for digital and real-time PCR, genotyping, single-cell gene expression, cancer detection and absolute quantification.

15 Oct 2009

Abortions worldwide decline, unsafe abortions kill 70,000 women annually, report says

Fewer abortions are taking place worldwide because of increased contraceptive use, a study by the Guttmacher Institute has found, Reuters reports. The study also indicates that 20 million "unsafe abortions, mostly in poorer countries and often carried out by the women themselves using inappropriate drugs or herbal potions, or by untrained traditional healers," still occur each year and kill 70,000 women annually (Kelland, 10/13).

15 Oct 2009

Kaviza launches VDI-in-a-box 2.0

Kaviza, the pioneer in affordable desktop virtualization, announces the general availability of VDI-in-a-box™ 2.0, the only turnkey VDI product that enables customers to deploy virtual desktops at the cost of a PC.

15 Oct 2009

Blocking folic acid action during early pregnancy leads to increased risk of abnormalities in growing baby

Using medication that reduces or blocks the actions of folic acid during the first trimester of pregnancy (weeks 1-12), increases the risk that the growing baby will develop abnormalities. This conclusion was reached by a team of Epidemiologists, Paediatricians, Clinical Pharmacologists, Obstetricians and Gynaecologists who examined birth and abortion data collected in Israel between 1998 and 2007.

15 Oct 2009

Atlantic examines flu vaccine, antiviral skepticism

As countries around the world roll out H1N1 (swine flu) virus vaccine campaigns, the Atlantic examines, "[W]hat if everything we think we know about fighting influenza is wrong?"

15 Oct 2009

Medications to reduce folic acid during pregnancy increase the risk of abnormalities in fetus

Pregnant women are advised to take vitamin supplements containing folic acid as part of their routine pre-natal care. Now, a new study warns that taking medications that reduce or block the actions of folic acid during the first trimester of pregnancy increase the risk that the growing baby will develop abnormalities.

14 Oct 2009

FDA approves ZyStor Therapeutics' ZC-701 for Phase I human safety trial

ZyStor Therapeutics, Inc., a biotechnology company developing a new class of targeted protein therapeutics for the treatment of Lysosomal Storage Diseases using the Company's proprietary Glycosylation Independent Lysosomal Targeting technology, today announced that it has received clearance from the U. S. Food and Drug Administration to proceed into a clinical trial for its first drug candidate, ZC-701, an enzyme replacement therapy for the treatment of Pompe disease.

14 Oct 2009

Solos Endoscopy to obtain the CE Mark for its MammoView line of surgical endoscopy instruments

Solos Endoscopy, Inc. is pleased to announce that the Company has taken the initial steps to obtain the CE Mark for its Food and Drug Administration (FDA) approved MammoView(TM) line of surgical endoscopy instruments. This will allow the MammoView(TM) line to be sold throughout the European Economic Union (EEU).

14 Oct 2009

Positive data from ZIOPHARM's palifosfamide sarcoma Phase II trial

ZIOPHARM Oncology, Inc. announced today positive top line interim data from the multicenter randomized Phase II trial of palifosfamide (ZymafosTM, ZIO-201) treating patients with unresectable or metastatic soft tissue sarcoma. The analysis evaluated 62 patients treated as of the end of September, with 58 being analyzed.

14 Oct 2009

EMEA grants ArQule's ARQ 197 orphan drug designation

ArQule, Inc. today announced that the European Medicines Evaluation Agency (EMEA) has designated ARQ 197 as an orphan medical product for the treatment of soft tissue sarcoma.

14 Oct 2009

Status report on the health care reform proposals in Congress

14 Oct 2009

Richmont Sciences to market PURE’s antimicrobial SDC disinfectants

PURE Bioscience announced that it has expanded its business strategy through an alliance with the Dallas-based sales and marketing team Richmont Sciences, LLC, which will begin actively selling PURE’s revolutionary new antibacterial, antiviral and antifungal hard surface disinfectant and its active ingredient.

14 Oct 2009

ACS to develop and maintain the Kentucky Health Information Exchange

Affiliated Computer Services, Inc., today announced that it has been awarded a contract that will help improve the quality of healthcare in Kentucky by providing physicians with a more complete picture of a patient’s medical history.

14 Oct 2009

Vision scientists identify an intricate process that allows the human eye to adapt quickly to darkness

Ever wonder how your eyes adjust during a blackout? When we go from light to near total darkness, cells in the retina must quickly adjust. Vision scientists at Washington University School of Medicine in St. Louis have identified an intricate process that allows the human eye to adapt to darkness very quickly. The same process also allows the eye to function in bright light.

14 Oct 2009

Ganeden Biotech and NFO announce new partnership agreement

Ganeden Biotech Inc., maker of the patented probiotic strain GanedenBC30®, today announced a new partnership agreement with the National Farmers Organization (NFO), a group marketing and price negotiation organization for the nation's farmers, ranchers and dairymen.

14 Oct 2009

Riga Eastern Clinical University Hospital commences treatment with the Novalis Tx radiosurgery platform

Doctors in Latvia have begun treatments using the region's first Novalis Tx(TM) radiosurgery platform from Varian Medical Systems and BrainLAB. Two prostate cancer patients have been treated using Varian's RapidArc® radiotherapy technology at the Riga Eastern Clinical University Hospital.

14 Oct 2009

Cochlear and NXP Semiconductors sign design and manufacturing agreement

Cochlear Limited, Australian based world leader in Implantable Hearing Solutions, and NXP Semiconductors announced today that they have signed an agreement for the design and manufacturing of IC devices for Cochlear’s future generation Implantable Hearing devices.

14 Oct 2009